← Back to Clinical Trials
Recruiting NCT06638554

NCT06638554 Integrating Telehealth to Advance Lung Cancer Screening

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06638554
Status Recruiting
Phase
Sponsor Abramson Cancer Center at Penn Medicine
Condition Early Detection of Cancer
Study Type INTERVENTIONAL
Enrollment 6,000 participants
Start Date 2024-07-09
Primary Completion 2027-01-31

Trial Parameters

Condition Early Detection of Cancer
Sponsor Abramson Cancer Center at Penn Medicine
Study Type INTERVENTIONAL
Phase N/A
Enrollment 6,000
Sex ALL
Min Age 50 Years
Max Age 80 Years
Start Date 2024-07-09
Completion 2027-01-31
Interventions
Active ChoiceTelehealth OnlyLow Touch Strategy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this pragmatic trial is to learn if telehealth strategies can increase shared decision-making (SDM) for lung cancer screening (LCS). It will also learn about the equity of these strategies by conducting non-inferiority analysis by race and sex. The main questions it aims to answer are: 1. Does patient outreach using synchronous and asynchronous telehealth strategies increase completion of SDM visits for LCS? 2. Is the effectiveness of these telehealth strategies similar by race and sex? The study uses a Sequential Multiple Assignment Randomized Trial (SMART) design and includes two stages of interventions. The first stage of intervention includes direct patient outreach with an invitation to schedule either a 1) telehealth SDM visit or 2) telehealth or in-person SDM visit. Participants that do not respond to the first stage interventions receive a text message reminder encouraging SDM visit completion with or without digital care coordination.

Eligibility Criteria

Inclusion criteria: Participants will be eligible if: 1. are aged 50 to 80 2. have a history of tobacco use indicated by either: Documented 20 pack-year or greater smoking history in their electronic health record (EHR); OR Self-report via structured survey 3. currently smoke or formerly smoked cigarettes 4. have no documented history of lung cancer 5. have no documented history of lung cancer screening in the 24 months prior to study enrollment 6. have completed at least one primary care visit at Penn Medicine in the 3 years prior to study enrollment. Exclusion criteria: Participants who do not meet inclusion criteria will not be eligible.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology